Catherine Stehman-Breen

Catherine Stehman-Breen is the CEO at Chroma Medicine. She became CEO in 2020 after serving as Chief Research and Development Officer at Obsidian Therapeutics.

Catherine has a BA from Colby College, a MA fro the University of Washington, and an MD from The University of Chicago Pritzker School of Medicine.